News
FDA approves Novavax COVID-19 vaccine
Digest more
The FDA has approved Merck’s Welireg (belzutifan), a hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor, for the treatment of adults and pediatric patients aged 12 and older with locally ...
Send in your questions here. End of carousel The FDA was on track to grant full approval for the vaccine April 1, according to two people familiar with the matter who spoke on the condition of ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Merck & Co. Inc.’s (NYSE:MRK) Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced ...
Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback